Glioma-infiltrating Tregs express particularly high levels of CCR4 compared to other tumor-infiltrating lymphocytes (73), and several in vitro migration studies have demonstrated the ability of glioma-derived CCL22 to induce Treg chemotaxis (71–73). The gene discussed is CCR4; the disease is glioma.